What are thrombosis risk and management considerations in COVID-19?
ACC Feature | Key Questions on COVID-19 and Cardiovascular Disease
cards; cards publication; 2019-nCoV
Principal Guidance: The apparent increased thrombotic risk in COVID-19 patients is sufficient to recommend pharmacological VTE prophylaxis in all hospitalized patients unless contraindicated; D-dimer levels may be valuable for clinical monitoring, but there is currently no evidence supporting its use to guide anticoagulation intensity beyond clinical judgment; post-discharge VTE prophylaxis with a DOAC should be considered.
Barnes, Geoffrey D.; Cuker, Adam; Gluckman, Tyler J; Piazza, Gregory; and Siegal, Deborah M., "What are thrombosis risk and management considerations in COVID-19?" (2020). Articles, Abstracts, and Reports. 4117.